Galapagos NV
GLPG
#4563
Rank
C$2.91 B
Marketcap
C$43.64
Share price
-0.57%
Change (1 day)
15.49%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -C$0.75 Billion

According to Galapagos NV's latest financial reports the company's current earnings are C$0.32 Billion. In 2024 the company made an earning of -C$7.99 Million, an increase over its 2023 earnings that were of -C$46.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.75 Billion9224.98%
2024 -C$7.99 Million-82.77%
2023 -C$46.34 Million-85.59%
2022 -C$0.33 Billion60.71%
2021 -C$0.21 Billion-60.08%
2020 -C$0.51 Billion-331.44%
2019 C$0.21 B-523.76%
2018 -C$51.13 Million-72.34%
2017 -C$0.19 Billion-329.59%
2016 C$80.5 M-144.3%
2015 -C$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
C$18.08 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
C$44.75 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.57 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
C$2.29 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-C$0.13 Billion-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.24 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.44 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$12.87 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$31.89 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA